eXoZymes, Inc.
EXOZ
$15.00
-$0.48-3.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.31M | 1.75M | 1.38M | 1.35M | 888.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.52M | 2.55M | 1.95M | 1.98M | 1.61M |
| Operating Income | -2.52M | -2.55M | -1.95M | -1.98M | -1.61M |
| Income Before Tax | -2.29M | -2.36M | -1.86M | -1.84M | -1.66M |
| Income Tax Expenses | -- | -- | -- | -2.10K | -- |
| Earnings from Continuing Operations | -2.29M | -2.36M | -1.86M | -1.84M | -1.66M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.29M | -2.36M | -1.86M | -1.84M | -1.66M |
| EBIT | -2.52M | -2.55M | -1.95M | -1.98M | -1.61M |
| EBITDA | -2.45M | -2.48M | -1.88M | -1.92M | -1.54M |
| EPS Basic | -0.27 | -0.28 | -0.22 | -0.24 | -0.26 |
| Normalized Basic EPS | -0.17 | -0.18 | -0.14 | -0.15 | -0.17 |
| EPS Diluted | -0.27 | -0.28 | -0.22 | -0.24 | -0.26 |
| Normalized Diluted EPS | -0.17 | -0.18 | -0.14 | -0.15 | -0.17 |
| Average Basic Shares Outstanding | 8.39M | 8.38M | 8.37M | 7.50M | 6.25M |
| Average Diluted Shares Outstanding | 8.39M | 8.38M | 8.37M | 7.50M | 6.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |